NAVB Stock Soars 55% on Impressive Data for NAV3-31
NAVB stock is the biggest biotech stock gainer in Tuesday’s trading session after Navidea Biopharmaceuticals Inc (NYSE:NAVB) announced positive results of the first interim analysis of its ongoing phase 2B study on rheumatoid arthritis. Solid ... [Read]